Laboratory service including quantitative determination of TARC (CCL17) biomarker in peripheral blood serum
Usługa laboratoryjna obejmująca ilościowe oznaczenia biomarkera TARC (CCL17) w surowicy krwi obwodowej
Poland · Gdańsk · how to bid here →
Your path to submission
- Deadline: 7 October at 10:00 — 4 days left.
- You submit on eZamówienia — not here and not by e-mail. ↗ Submission via eZamówienia: account required; above the EU threshold a qualified signature, nationally the 'trusted signature' often suffices — check the wording. Sort out account and signature first — not on submission day.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 3 months (20 awards, most recently March 2026) — by that rhythm the next award was due around June 2026. The last award went to E-Trust sp. z o.o. ,.n = 20
- 42% of this buyer's awards went to companies that had already won here before (1,138 awards since 2015, spread over 438 companies). 58% went to new names.n = 1,138 awards since 2015
- The award came in at a median 80% of the estimated value (39 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 99%.n = 39
- 95% of the bids received came from small and medium-sized enterprises (55 procedures with a bid mix). Sector: 70%.n = 55
- The median procedure drew just one bid (302 procedures with a bid count); 54% ended with a single bidder. Sector: median 1 bids.n = 302
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 27/09/2026.
Foreign bidders
In Poland · IT services, 234 contracts went to foreign companies over the last 3 years (of 12,696 recorded awards) — mostly from Bulgaria, Germany, Belgium.
Typical field: median 1 (from 3,004 awards).
What the buyer is looking for
1. The subject of the contract is the provision of a comprehensive laboratory service including: quantitative TARĆ biomarker determination (CCL17) in peripheral blood serum, management, analysis and archiving of laboratory data, reporting of results in the N-BRAVE clinical trial (PLRG-HL05): ‘Evaluation of the efficacy and tolerability of the N-AVD regimen compared to the BrECADD regimen in patients with advanced Hodgkin lymphoma’ for the needs of the Medical University of Gdańsk. 2. The study is funded by the Medical Research Agency (ABM) contract No 2024/ABM/02/00001. 3. A detailed description of the subject, scope and method of implementation is described in the description of the subject of the contract constituting Annex 3 to these Terms and Conditions.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Eppendorf Poland Sp. z o .o. Al. Jerozolimskie 212 02-486 | 30 | 2021–2026 |
| VWR INTERNATIONAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ | 22 | 2021–2026 |
| Biogenet Sp. z o.o. | 19 | 2021–2026 |
| Donserv Wojciech Kaca | 17 | 2021–2026 |
| Simedu Sp. z .o.o. | 16 | 2021–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.
How to bid
Guide: how to apply on e-Zamówienia (Polen) → Registration, signature, fees — from the operator's bidder manual.